The ability of physicians to effectively treat and cure cancer is directly dependent on their ability to detect cancers at their early stages. The early detection of cancer has the potential to dramatically reduce mortality. Recently, the use of mass spectrometry to develop profiles of patient serum proteins has been reported as a promising method to achieve this goal.
Introduction
The early detection of cancer is crucial for its ultimate control and prevention (1, 2) . Although advances in conventional diagnostic strategies such as mammography and prostate-specific antigen (PSA) testing have provided some improvement in the detection of disease, they still do not reach the sensitivity and specificity that are needed to reliably detect early-stage disease. Recently, proteomic analyses of early-stage cancers have provided new insights into the changes that occur in the early phases of tumorigenesis and represent a new resource of candidate biomarkers for early-stage disease (1) (2) (3) (4) .
A revolutionary proteomic technology has been developed that uses the pattern of proteins observed within a clinical sample as a diagnostic fingerprint and does not rely on the identification of the proteins detected. In its current state, surfaceenhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) is the technology used to acquire the proteomic patterns to be used in the diagnostic setting (5, 6) . The principle of SELDI-TOF is very simple: proteins of interest are captured, by adsorption, partition, electrostatic interaction, or affinity chromatography, on a stationary-phase and immobilized in an array format on a chip surface. One of the benefits of this process is that raw biofluids, such as urine, serum and plasma, can be directly applied to the array surface. After a series of binding and washing steps, a matrix is applied to the array surfaces. The species bound to these surfaces can be ionized by matrix-assisted laser desorption/ionization (MALDI) and their mass-to-charge (M/Z) ratios measured by TOF MS. The result is a mass spectrum of the species that are bound to and subsequently desorbed from the array surface (1).
The use of SELDI-TOF MS profiling of protein serum proteins, combined with advanced data mining algorithms, to detect protein patterns associated with malignancy, has been reported as a promising field of research to achieve the goal of early cancer detection (3, (7) (8) (9) (10) (11) . Research had showed the ability of this proteomic method to diagnose the difference between ovarian cancer (12-14), prostate cancer (4, 15-18), and bladder cancer (18, 19) . Much of the effort in these analyses has focused on the use of a variety of data mining tools such as the evaluation of prostate cancer using peaks in the mass to charge (M/Z) region between 2 K and 40 K combined with boosted decision tree analysis (15) to try to detect patterns that allow the diagnosis of cancer versus non-cancer (3). The use of similar technology to evaluate bladder cancer has also been reported (18, 19) . Thus, this field represents an active area of current research (3).
There is growing interest in the application of machine learning techniques in bioinformatics. Supervised machine learning approaches, such as support vector machine (SVM), have been widely applied to bioinformatics and have gained a lot of success in this research area. In this study, we investigate the use of SVM to analyze serum proteomic patterns for early cancer detection.
Material and Method

Data Sets
In this study, we used the following data sets obtained from Clinical Proteomic Program Databank (http://clinicalproteomics.steem.com). We briefly describe the biological motivation for the data sets; interested readers should refer to the cited papers for details.
Ovarian Cancer. The first group of data is a set of ovarian cancer samples that was first reported in (12). The goal of the experiment in (12) is to identify proteomic patterns in serum that distinguish ovarian cancer from non-cancer. That study is significant to women who have a high risk of ovarian cancer due to family or personal history of cancer. The proteomic spectra were generated by mass spectroscopy. Our experiments and results reported in this paper are based on the data set 6-19-02, which consists of 91 controls (non-cancer) and 162 ovarian cancers.
Prostate Cancer. The second group of data is a set of prostate cancer sample. The experiment analyzed serum proteomic mass spectra generated by SELDI-TOF to discriminate the sera of men with histopathologic diagnosis of prostate cancer (serum prostate-specific antigen [PSA] ≥ 4 ng/mL) from those men without prostate cancer (serum PSA < 1 ng/mL). In this data set, there are 63 control (non-cancer) samples, and 69 cancer samples.
Data Normalization
The relative amplitude of the intensity at each molecular mass/charge (M/Z) identity in the spectral data was normalized against the most intense and the least intense values in the data stream according to the formula:
where NV is the normalized value, V the raw value, Min the minimum intensity, and Max the maximum intensity. The normalization is done over all the samples for all M/Z identities. After the normalization, each intensity value is in the range between 0 and 1 (3).
Classifier
In this study, Support Vector Machine (SVM) was used for serum proteomic pattern analysis.
SVM is a kind of blend of linear modeling and instance-based learning. An SVM selects a small number of critical boundary samples, called support vectors, from each category and builds a linear discriminate function that separates them as widely as possible. In the case that no linear separation is possible, the technique of "kernel" will be used to automatically inject the training samples into a higher-dimensional space, and to learn a separator in that space (20) . In linearly separable cases, SVM constructs a hyperplane which separates two different categories of feature vectors with a maximum margin, i.e., the distance between the separating hyperplane and the nearest training vector. The training instances that lie closest to the hyperplane are support vectors. The hyperplane was constructed by finding another vector w, and a parameter b that minimizes ||w|| 2 and satisfies the following conditions:
where y i is the category index (i.e., cancer, non-cancer), w is a vector normal to the hyperplane, |b|/||w|| is the perpendicular distance from the hyperplane to the origin and ||w|| 2 is the Euclidean norm of w. After the determination of w and b, a given vector x can be classified by sign
In this paper, SVMLight v.3.5 was used (20). Linear kernel, polynomial kernel, and radial kernel were applied.
Feature Selection
The feature selection method used in this study is MIT correlation, which is also known as signal-to-noise statistic (22). For a given feature i, we compute the mean and standard deviation When making selection, we simply take those features with the highest scores as the most discriminatory features.
Cross-validation of the Models
The normal method to evaluate the classification results is to perform cross-validation on the classification algorithms (23). Tenfold cross-validation has been proven to be statistically good enough in evaluating the classification performance (21, 24) . In this paper, each of the two data sets (ovarian cancer and prostate cancer data sets) was partitioned into ten subsets with both cancer samples and non-cancer samples spread as equally as possible between the sets. Each of these sets in turn was set aside while a model was built using the other nine sets. This model was then used to classify the samples in the tenth set, and the accuracy computed by comparing these predictions with the actual category. This process was repeated ten times and the results averaged (21).
Performance Measures
Several statistics were used as performance measures: 
Results
The results were shown in Table I . From the results, we observed that, in general, SVM performed well on these two data sets, in terms of sensitivity, specificity, and accuracy. Linear kernel worked the best on ovarian cancer data, while polynomial kernel worked best on prostate cancer data. When linear kernel was applied, SVM can correctly classify ovarian cancer samples and non-cancer samples with an accuracy of 0.97 and a sensitivity of 0.99. No ovarian sample was mis-classified as non-cancer sample (false negative = 0) when polynomial kernel was used, which can be observed, in Table I , that the sensitivity and NPV were 1's. When radial kernel was applied, all the samples in either of the two data sets were predicted as cancer samples. Therefore, the specificity was 0.
In this study, the MIT was used as the feature selection method to test if feature selection can improve SVM performance on the two cancer data sets. Figure 1 and Figure 2 showed the effect of feature selection on SVM performance with different kernel types ( Figure 1A obtained when all the features (15,154) were used. Similar observations had been reported in text classification (25) (26) (27) , and drug discovery (21). Taira and Haruno (28) compared SVM and decision tree in text categorization, and the best average performance was achieved when all the features were given to SVM, which was a distinct characteristic of SVM compared with the decision tree learning algorithm. Joachims (29) argued that, in text classification, feature selection was often not needed for SVM, as SVM tends to be fairly robust to overfitting and can scale up to considerable dimensionalities.
Discussion
The advent of proteomic has brought with it the hope of discovering novel biomarkers that can be used to diagnose diseases, predict susceptibility, and monitor progression. A revolutionary approach in proteomic pattern analysis has emerged as an effective method for the early diagnosis of diseases such as ovarian cancer and prostate cancer. Proteomic pattern analysis relies on the pattern of protein observed and does not rely on the identification of a traceable biomarker. Hundreds of clinical samples were generated each day. Such large high-throughput collections of data require powerful tool to assist data analysis.
Machine learning has increasingly gained attention in bioinformatics research. Machine learning is the subfield of artificial intelligence which focuses on methods to construct computer programs that learn from experience with respect 
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Sn Sp Accuracy PPV NPV B A to some class of tasks and a performance measure (21). Machine learning methods are suitable for molecular biology data due to the learning algorithm's ability to construct classifiers/ hypotheses that can explain complex relationships in the data. Therefore, machine learning has increasingly gained attention in bioinformatics research. Early cancer detection remains a challenging task in identifying potential points for therapeutics intervention, understanding tumor behavior and also facilitating drug development. In this paper, we applied SVM to serum proteomic pattern analysis for cancer early detection.
When support vector machine is applied, each vector of the test sample values (control or cancer samples) in the proteomic matrix may be thought of as a point in an m-dimensional expression space. In theory, a simple way to build a binary classifier is to construct a hyperplane separating class members (positive examples) from non-members (negative examples) in this space (30, 31) . Unfortunately, most realworld problems involve non-separable data for which there does not exist a hyperplane that successfully separates the positive from the negative examples. One solution to the inseparability problem is to map the data into a higher-dimensional space and define a separating hyperplane there. This higher dimensional space is called the feature space, as opposed to the input space occupied by the training examples. With an appropriately chosen feature space of sufficient dimensionality, any consistent training set can be made separable. However, translating the training set into a higher-dimensional space incurs both computational and learning-theoretic costs. Furthermore, artificially separating the data in this way exposes the learning system to the risk of finding trivial solutions that overfit the data (30).
SVMs elegantly sidestep both difficulties (31). They avoid overfitting by choosing the maximum margin separating hyperplane from among the many that can separate the positive from negative examples in the feature space. Also, the decision function for classifying points with respect to the hyperplane only involves dot products between points in the feature space. Because the algorithm that finds a separating hyperplane in the feature space can be stated entirely in terms of vectors in the input space and dot products in the feature space, a support vector machine can locate the hyperplane without ever representing the space explicitly, simply by defining a function, called a kernel function, that plays the role of the dot product in the feature space. This technique avoids the computational burden of explicitly representing the feature vectors (30).
Other machine learning techniques were applied to proteomics pattern analysis to predict cancers. Petricoin et al. (12) demonstrated that the use of genetic algorithms coupled with self-organizing cluster analysis can result the rules for ovarian cancer prediction. The disadvantage of genetic algorithm is that it requires long time to train the model and the result could be a sub-optimal model. It is fast to train SVM models. Because SVM is powerful in classification, it has been widely used for gene function prediction from gene expression data (32, 33), cancer tissue classification from gene expression data (34), protein folding recognition (35-37), protein-protein interaction prediction (38), and protein secondary structure prediction (39).
We have demonstrated that support vector machines can accurately classify the cancer samples based on serum proteomic pattern. We believe these approaches have significant potential in proteomic pattern analysis for early cancer detection.
